You are here

Home / Resources / Key Material
Export 66 results:
Filters: First Letter Of Last Name is W  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
W
Weir, M. H., & Haas C. N. (2009).  Quantification of the Effects of Age on the Dose Response of Variola major in Suckling Mice. Human and Ecological Risk Assessment. 15, 1245–1256.
Weir, M. H. (2009).  Development of a Physiologically Based Pathogen Transport and Kinetics Model for the Inhalation of ''Bacillus anthracis'' Spores.
Weir, M.. H., Mitchell J.., Flynn W.. B., & Pope J.. M. (2016).  Development of a Microbial Dose Response Visualization and Modelling Application for QMRA Modelers and Educators.
Weir, M. H. (2019).  A data simulation method to optimize a mechanistic dose-response model for viral loads of hepatitis A. Microbial Risk Analysis. 100102.
Weir, M. H., Mitchell J., Flynn W., & Pope J. M. (2017).  Development of a microbial dose response visualization and modelling application for QMRA modelers and educators. Environmental Modelling & Software. 88, 74–83.
Weir, M.. H. (2016).  Dose-Response Modeling and Use: Challenges and Uncertainties in Environmental Exposure. In Manual of Environmental Microbiology. 3, 5.
Weir, M. H., & Haas C. N. (2011).  A model for in-vivo delivered dose estimation for inhaled Bacillus anthracis spores in humans with interspecies extrapolation. Environmental science & technology. 45, 5828–5833.
Weir, M. H. (2017).  Legionella pneumophila: Dose Response Models.
Weir, M. H. (2009).  Development of physiologically based pathogen transport and kinetics model for inhalation of Bacillus anthracis spores.
Weir, M. H., & Haas C. N. (2009).  Quantification of the Effects of Age on the Dose Response of Variola major in Suckling Mice. Human and Ecological Risk Assessment: An International Journal. 15, 1245–1256.
Weir, M.. H., & Haas C.. N. (2011).  A Model for In-vivo Delivered Dose Estimation for Inhaled ''Bacillus anthracis'' Spores in Humans with Interspecies Extrapolations. Environmental Science and Technology. 45, 5828-5833.
Weiss, E.., & Moulder J.. W. (1984).  The rickettsias and chlamydias. (Kreig, N.. R., & Holt J.. G., Ed.).Bergey's manual of systematic bacteriology. 687-739.
Weller, PF. (2012).  Protozoal Intestinal Infections and Trichomoniasis.
Wennerås, C.., & Erling V.. (2004).  Prevalence of enterotoxigenic Escherichia coli-associated diarrhoea and carrier state in the developing world. Journal of Health, Population, and Nutrition. 22, 370-382.
Westerman, E.. L. (1982).  Rocky Mountain spotless fever: A dilemma for the clinician. Arch. Intern. Med. 142, 1106-1107.
Westrell, T., Dusch V., Ethelberg S., & Harris J. (2010).  Norovirus outbreaks linked to oyster consumption in the United Kingdom, Norway, France, Sweden and Denmark, 2010.
White, D. O., & Fenner F. J. (1994).  Medical Virology.
WHO, WHO. (2003).  Guidelines for safe recreational water environments. Coastal and Fresh Waters. 1, 1–219.
WHO/HSE/WHS, (2009).  Risk Assessment of Criptosporidium in Drinking Water.
Wilhelmi, I., Roman E., & A Fauquier S. - (2003).  Viruses causing gastroenteritis.
Will, R. G., Ironside JW., Zeidler M., Estibeiro K., Cousens SN., Smith PG., et al. (1996).  A new variant of Creutzfeldt-Jakob disease in the UK. The Lancet. 347, 921–925.
Williams, D., Irvin E. A., Chmielewski R. A., & May) F. J. F.( (Submitted).  Dose-Response of Listeria monocytogenes after Oral Exposure in Pregnant Guinea Pigs. Journal of Food Protection. 70, 5.
Williams, J. C., & Cantrell J. L. (1982).  Biological and immunological properties of Coxiella burnetii vaccines in C57BL/1OScN endotoxin-nonresponder mice. Infection and Immunity. 35, 1091-1102.
Williams, J.. C., & Cantrell J.. L. (1982).  Biological and immunological properties of Coxiella burnetii vaccines in C57BL/10ScN endotoxin-nonresponder mice. Infection and Immunity. 35, 3.
Willocks, LJ., Sufi F., Wall R., Seng C., & Swan AV. (2000).  Compliance with advice to boil drinking water during an outbreak of cryptosporidiosis. Outbreak Investigation Team.. Communicable Disease and Public Health. 3, 137–138.